US firm acquires Cork health tech start-up

A Cork-founded health tech start-up has been acquired by US DNA and health tech company Nucleus.

Cambrean, which is an AI-based health platform that maps the relationships between sleep, nutrition, workouts, and vitals, and creates algorithms that allow users to track everyday factors that impact their health, was founded in Cobh in 2021.

Data from the platform combines baseline genetic assessments with real-time tracking from wearables such as smart watches, giving users a clear roadmap to mitigating their risks for chronic diseases.

Nucleus, a US-based company, creates algorithms to transform this type of data into actionable health assessments.

The acquisition will now enable Nucleus to “bridge the gap in these rich data points, woven together by a person’s genetic insights, for full picture of health information”, Nucleus stated.

“As we’ve gotten to know the Nucleus team, it’s become clear that we both share the same vision for what is possible in the future of healthcare,” said Cambrean co-founder CEO, Cork man David Sloane.

“Together, we’re going to combine continuous health monitoring with whole-genome sequencing for the very first time.”

Kian Sadeghi, founder and CEO of Nucleus, said: “Thoughtfully integrating each data point with DNA is the way to tell the complete story about someone’s health, [and] that’s what we plan on doing with Cambrean.

“We’re reimagining healthcare by building a data-rich, AI-driven ecosystem that begins with genetic insights and extends to every aspect of personal health management,” added Mr Sadeghi.

The acquisition follows the successful close of a $14m (€13.4m) Series A, bringing Nucleus’s total funding to nearly $32m.

The round includes new funding from Neo, Giant Step Capital, One Eight Capital, and notable angels including Balaji Srinivasan and Achal Upadhyaya.

The company also received continued support from Ohanian’s Seven Seven Six and Peter Thiel’s Founders Fund, who led previous rounds.